Company Overview and News


Add CDNA
to your dashboard

Headline News

Teladoc Rides on Growing Demand for Telehealth Services

2017-11-15 zacks
Teladoc Inc. (TDOC - Free Report) , a premier telehealth services provider, is expanding its business in the booming telehealth services industry. Increased adoption of the company’s services has led to growth in memberships and visits. This in turn has been generating substantial revenues. The company’s revenues have increased at a CAGR of 80% from 2013-2016. The trend was maintained in the first nine months of 2017. (66-0)

CareDx's (CDNA) CEO Peter Maag on Q3 2017 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Good day, ladies and gentlemen, and welcome to the CareDx Third Quarter 2017 Earnings Call. Today’s conference is being recorded. And at this time, I’d like to turn the floor over to David Clair, ICR, Investor Relations. Please go ahead. (2-0)

Low Waste Revenues to Hurt Stericycle's (SRCL) Q3 Earnings?

2017-11-06 zacks
Waste management firm Stericycle, Inc. (SRCL - Free Report) is scheduled to report third-quarter 2017 results after the closing bell on Nov 8. The company is likely to report lower revenues in Regulated Waste and Compliance Services segment that accounts for more than half of total revenues, due to stiff industry-wide competition. This is likely to result in lower earnings for the quarter. Top-Line Woes Stericycle operates in a highly-competitive market. (5-0)

Will Tinder & PMC Growth Aid Match Group (MTCH) Q3 Earnings?

2017-11-04 zacks
Match Group, Inc. (MTCH - Free Report) is set to report third-quarter 2017 earnings results on Nov 8. (13-0)

10 Cheap Stocks to Buy With Only $12 | InvestorPlace

2017-11-01 investorplace
Cheap stocks can be a smart choice for investors, as there are serious bargains to be found. The stocks below may be cheap, but they all offer impressive value for money and big upside potential. (84-1)

PAREXEL's Acquisition by Pamplona Approved by Shareholders

2017-09-27 zacks
PAREXEL International Corporation (PRXL - Free Report) is again in the news following the receipt of shareholders’ approval for the impending sell-off of the company to certain investment funds associated with Pamplona Capital Management. The transaction is expected to be completed by Sep 29 following which the company will turn into a privately-held organization (15-0)

CareDx Release: MolDX Sets AlloSure Reimbursement At 2017 AlloMap Level

2017-09-26 devicespace
BRISBANE, Calif., Sept. 26, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, received notice that the Molecular Diagnostics Services (MolDX) Program developed by Palmetto GBA has set AlloSure reimbursement at $2,840.75, which is same reimbursement as AlloMap in 2017. (2-0)

CareDx's (CDNA) CEO Peter Maag on Q2 2017 Results - Earnings Call Transcript

2017-08-11 seekingalpha
Good day, ladies and gentlemen, and welcome to the CareDx 2017 Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. And later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded.

CareDx Describes Extensive Analytical Validation Data On AlloSure Robustness At

2017-08-07 devicespace
BRISBANE, Calif., Aug. 04, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focusing on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, described rigorous evidence of the analytical robustness of AlloSure testing at the annual American Association of Clinical Chemistry Annual Meeting on Wednesday, August 2, 2017.

CareDx Release: 100,000th AlloMap Result Provided To Heart Transplant Patients

2017-07-13 devicespace
BRISBANE, Calif., July 13, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focusing on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, announced today that the landmark 100,000th AlloMap result has been provided.

Asset Acquisitions Accelerate in Healthcare Sector Boosting Potential Revenue Growth

2017-07-11 prnewswire
The healthcare sector one was of the better performing sectors in the second quarter and appears to be not far behind the tech sector looking at the year-to-date performance. Healthcare stocks continue to rally upon expectations of a favorable policy environment. The longer-term outlook for the healthcare sector appears to be positive as the sector is a direct beneficiary of the world's demographic trends. (0-1)

Land on 5 Winning Stocks with the Ignored Rising P/E Trick

2017-07-11 zacks
Trying hands at bargain stocks that have a low price-to-earnings (P/E) ratio is a common practice. The perception is that the lower the P/E, the higher will be the value of the stock. This inference is drawn on the simple logic that a stock’s current market price does not justify (is not equivalent to) its higher earnings and therefore has room to run.

CareDx Activities At

2017-05-30 devicespace
BRISBANE, Calif., May 30, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, will highlight CareDx’s Olerup pre-transplant diagnostics at the 31st European Immunogenetics and Histocompatibility Conference from May 30 – June 2, 2017 in Mannheim/Heidelberg, Germany.

What's in the Cards for Box, Inc (BOX) in Q1 Earnings?

2017-05-26 zacks
Box, Inc. (BOX - Free Report) is set to report first-quarter fiscal 2018 results on May 31. Last quarter, the company delivered a positive earnings surprise of 6.67%.

CareDx's (CDNA) CEO Peter Maag on Q1 2017 Results - Earnings Call Transcript

2017-05-23 seekingalpha
Good day ladies and gentlemen and welcome to the CareDx 2017 Q1 Preliminary Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following the management's prepared remarks, we'll host a question-and-answer session and our instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes.

CUSIP: 14167L103